Avricore Health Inc. (TSE:AVCR)
:AVCR
Want to see TSE:AVCR full AI Analyst Report?
AVCR Stock Chart & Stats
C$0.05
>-C$0.01(-8.33%)
At close: 4:00 PM EST
C$0.05
>-C$0.01(-8.33%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.10
Previous CloseN/A
Volume23.00K
Average Volume (3M)51.37K
Market Cap
C$5.57M
Enterprise ValueC$4.84M
Total Cash (Recent Filing)C$210.30K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding101,289,665
10 Day Avg. Volume29,762
30 Day Avg. Volume51,367
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)13.00
Price to Sales (P/S)9.49
P/FCF Ratio-5.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Minimal DebtThe company carries essentially no debt, which reduces fixed financing costs and bankruptcy risk. For a small healthcare tech firm this conservatism preserves operational flexibility, allowing management to prioritize product deployment or partnership building without near-term interest burdens.
Platform-based Recurring Revenue Model (HealthTab)Avricore’s HealthTab platform and pharmacy testing programs create a structural revenue stream from software, connectivity and program fees. Platform-based recurring charges support predictable revenue as site scale increases and can create durable customer relationships and upsell opportunities.
Historic Gross Margin Strength Indicates Unit EconomicsPrior ~44% gross margins show the business has potential for healthy unit economics when volume and mix are favorable. That historical margin level implies services and software can be high-margin, giving a clear path to profitability if direct costs and utilization normalize.
Bears Say
Severe Revenue CollapseA ~73% TTM revenue decline is structurally damaging: it reduces scale benefits, undermines recurring revenue expectations, weakens negotiating power with pharmacy partners, and magnifies the burden of fixed costs, making margin recovery and growth substantially harder.
Negative Operating And Free Cash FlowRecent conversion to negative operating and free cash flow signals ongoing cash burn. Persistent cash consumption limits ability to fund program rollouts or marketing internally and increases dependence on external capital, raising short-to-medium-term execution risk.
Eroding Equity And Dilution RiskMaterial decline in shareholders' equity reflects sustained losses and reduces the balance sheet buffer. A thin equity base increases the probability of equity financings, which can dilute shareholders and constrain long-term strategic investments if additional capital is required to stabilize operations.
Avricore Health News
AVCR FAQ
What was Avricore Health Inc.’s price range in the past 12 months?
Avricore Health Inc. lowest stock price was C$0.04 and its highest was C$0.10 in the past 12 months.
What is Avricore Health Inc.’s market cap?
Avricore Health Inc.’s market cap is C$5.57M.
When is Avricore Health Inc.’s upcoming earnings report date?
Avricore Health Inc.’s upcoming earnings report date is Sep 02, 2026 which is in 80 days.
How were Avricore Health Inc.’s earnings last quarter?
Currently, no data Available
Is Avricore Health Inc. overvalued?
According to Wall Street analysts Avricore Health Inc.’s price is currently Overvalued.
Does Avricore Health Inc. pay dividends?
Avricore Health Inc. does not currently pay dividends.
What is Avricore Health Inc.’s EPS estimate?
Avricore Health Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avricore Health Inc. have?
Avricore Health Inc. has 101,289,665 shares outstanding.
What happened to Avricore Health Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Avricore Health Inc.?
Currently, no hedge funds are holding shares in TSE:AVCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Avricore Health Inc.
Avricore Health Inc. operates within Canada, specializing in health data management and point-of-care technological solutions. Their primary offering is HealthTab, a precise, laboratory-quality diagnostic testing system designed for use in pharmacies. This enterprise maintains key alliances with prominent organizations such as Shoppers Drug Marts and Abbott. Established in 1996 and headquartered in Vancouver, Canada, the company previously operated as Vanc Pharmaceuticals Inc., adopting its current name, Avricore Health Inc., in October 2018.
Technical Analysis
BioMark Diagnostics
―
Telo Genomics Corp
―
StageZero Life Sciences Ltd
―
―
PanGenomic Health, Inc. Class A
―
Options Prices
Currently, No data available
---